| N6-methylandenosine-related lncRNAs are potential biomarkers for predicting the overall survival of lower-grade glioma patients Z Tu, L Wu, P Wang, Q Hu, C Tao, K Li, K Huang, X Zhu Frontiers in cell and developmental biology 8, 642, 2020 | 137 | 2020 |
| Identification of RNA: 5-methylcytosine methyltransferases-related signature for predicting prognosis in glioma P Wang, M Wu, Z Tu, C Tao, Q Hu, K Li, X Zhu, K Huang Frontiers in Oncology 10, 1119, 2020 | 32 | 2020 |
| Protein disulfide-isomerase A3 is a robust prognostic biomarker for cancers and predicts the immunotherapy response effectively Z Tu, Q Ouyang, X Long, L Wu, J Li, X Zhu, K Huang Frontiers in Immunology 13, 837512, 2022 | 27 | 2022 |
| Ferroptosis in tumor immunity and therapy C Gong, Q Ji, M Wu, Z Tu, K Lei, M Luo, J Liu, L Lin, K Li, J Li, K Huang, ... Journal of Cellular and Molecular Medicine 26 (22), 5565-5579, 2022 | 19 | 2022 |
| A novel signature constructed by RNA-binding protein coding genes to improve overall survival prediction of glioma patients Z Tu, L Shu, J Li, L Wu, C Tao, M Ye, X Zhu, K Huang Frontiers in Cell and Developmental Biology 8, 588368, 2021 | 14 | 2021 |
| CLCF1 Is a novel potential immune-related target with predictive value for prognosis and immunotherapy response in glioma Y Jiang, Q Ji, X Long, P Wang, Z Tu, X Zhang, X Zhu, K Huang, J Li Frontiers in immunology 13, 810832, 2022 | 13 | 2022 |
| Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower‐grade gliomas Q Ji, K Huang, Y Jiang, K Lei, Z Tu, H Luo, X Zhu Cancer Medicine 11 (9), 2020-2035, 2022 | 12 | 2022 |
| Sperm autoantigenic protein 17 predicts the prognosis and the immunotherapy response of cancers: A pan-cancer analysis Z Tu, J Peng, X Long, J Li, L Wu, K Huang, X Zhu Frontiers in Immunology 13, 844736, 2022 | 9 | 2022 |
| Protein disulfide-isomerase A4 confers glioblastoma angiogenesis promotion capacity and resistance to anti-angiogenic therapy Z Tu, C Wang, Q Hu, C Tao, Z Fang, L Lin, K Lei, M Luo, Y Sheng, X Long, ... Journal of Experimental & Clinical Cancer Research 42 (1), 77, 2023 | 7 | 2023 |
| Transcriptional Patterns of Lower‐Grade Glioma Patients with Distinct Ferroptosis Levels, Immunotherapy Response, and Temozolomide Sensitivity Z Tu, J Li, X Long, L Wu, X Zhu, K Huang Oxidative medicine and cellular longevity 2022 (1), 9408886, 2022 | 7 | 2022 |
| DNAJC10 correlates with tumor immune characteristics and predicts the prognosis of glioma patients F Liu, Z Tu, J Liu, X Long, B Xiao, H Fang, K Huang, X Zhu Bioscience Reports 42 (1), BSR20212378, 2022 | 7 | 2022 |
| Pan-cancer analysis of N4-acetylcytidine adaptor THUMPD1 as a predictor for prognosis and immunotherapy K Li, J Liu, X Yang, Z Tu, K Huang, X Zhu Bioscience Reports 41 (12), BSR20212300, 2021 | 7 | 2021 |
| Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy Z Tu, K Li, Q Ji, Y Huang, S Lv, J Li, L Wu, K Huang, X Zhu BMC cancer 23 (1), 133, 2023 | 6 | 2023 |
| Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients Y Hu, Z Tu, K Lei, K Huang, X Zhu Bioscience Reports 41 (12), BSR20211640, 2021 | 5 | 2021 |
| Integrin Alpha-2 as a potential prognostic and predictive biomarker for patients with lower-grade glioma L Lin, K Huang, Z Tu, X Zhu, J Li, K Lei, M Luo, P Wang, C Gong, X Long, ... Frontiers in Oncology 11, 738651, 2021 | 5 | 2021 |
| Comprehensive analysis of the prognostic implications and functional exploration of PAK gene family in human cancer K Lei, M Luo, Z Tu, S Lv, J Liu, C Gong, M Ye, M Wu, Y Sheng, X Long, ... Cancer Cell International 22 (1), 275, 2022 | 3 | 2022 |
| Prognostic and predictive value of immune-related gene pair signature in primary lower-grade glioma patients K Lei, J Li, Z Tu, F Liu, M Ye, M Wu, Y Zhu, M Luo, L Lin, C Tao, K Huang, ... Frontiers in Oncology 11, 665870, 2021 | 3 | 2021 |
| Systematic and multi-omics prognostic analysis of lysine acetylation regulators in glioma Z Tu, L Wu, H Luo, J Li, S Lv, M Ye, F Liu, C Tao, X Zhu, K Huang Frontiers in Molecular Biosciences 8, 587516, 2021 | 3 | 2021 |
| The role of lysosomal peptidases in glioma immune escape: underlying mechanisms and therapeutic strategies H Liu, J Peng, L Huang, D Ruan, Y Li, F Yuan, Z Tu, K Huang, X Zhu Frontiers in Immunology 14, 1154146, 2023 | 2 | 2023 |
| The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker Z Tu, X Wang, H Cai, Y Sheng, L Wu, K Huang, X Zhu Aging (Albany NY) 15 (6), 2136, 2023 | 2 | 2023 |
